Results of a phase II study of liposomal doxorubicin (Myocet<SUP>?</SUP>) in combination with weekly paclitaxel and trastuzumab (Herceptin<SUP>?</SUP>) In patients with HER2-positive locally advanced or metastatic breast cancer (LA/MBC)

J.Baselga; M.A.Climent; A.Lluch; J.Hornedo; P.Gascon; A.T.Sanchez; V.Guillem; H.Corte′s-Funes; P.Regueiro; J.Trigo

首页> 外文期刊>European Journal of Cancer Supplements >Results of a phase II study of liposomal doxorubicin (Myocet^?) in combination with weekly paclitaxel and trastuzumab (Herceptin^?) In patients with HER2-positive locally advanced or metastatic breast cancer (LA/MBC)

【24h】

Results of a phase II study of liposomal doxorubicin (Myocet^?) in combination with weekly paclitaxel and trastuzumab (Herceptin^?) In patients with HER2-positive locally advanced or metastatic breast cancer (LA/MBC)

机译：脂质体阿霉素（Myocet ^{？）联合每周紫杉醇和曲妥珠单抗（Herceptin ^{？）在HER2阳性局部晚期或转移性乳腺癌患者中的II期研究结果（LA / MBC）}}

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2004年第3期|共1页
作者
J.Baselga; M.A.Climent; A.Lluch; J.Hornedo; P.Gascon; A.T.Sanchez; V.Guillem; H.Corte′s-Funes; P.Regueiro; J.Trigo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer [J] . BaselgaJ., ManikhasA., CortésJ., Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第3期

机译：非聚乙二醇脂质体阿霉素联合曲妥珠单抗和紫杉醇治疗HER2阳性转移性乳腺癌的III期试验
2. Primary Results From EMILIA, a Phase III Study of Trastuzumab Emtansine (T-DM1) Versus Capecitabine (X) and Lapatinib (L) in HER2-Positive Locally Advanced or Metastatic Breast Cancer (MBC) Previously Treated With Trastuzumab (T) and a Taxane [J] . Clinical advances in hematology & oncology: H&O . 2012,第Suppla14期

机译：EMILIA的主要结果是曲妥珠单抗Emtansine（T-DM1）与卡培他滨（X）和拉帕替尼（L）在先前用曲妥珠单抗（T）和紫杉烷治疗的HER2阳性局部晚期或转移性乳腺癌（MBC）中的三阶段研究。
3. BOLERO-1: A Randomized, Phase III, Double-Blind, Placebo-Controlled Multicenter Trial of Everolimus in Combination With Trastuzumab and Paclitaxel as First-Line Therapy in Women With HER2-Positive (HER2 + ), Locally Advanced or Metastatic Breast Cancer (BC) [J] . Clinical advances in hematology & oncology: H&O . 2012,第Suppla14期

机译：BOLERO-1：依维莫司联合曲妥珠单抗和紫杉醇作为一线治疗对HER2阳性（HER2 +），局部晚期或转移性乳腺癌的女性进行的随机，III期，双盲，安慰剂对照的依维莫司多中心试验公元前）
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Editors choice: Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer [O] . J. Baselga, A. Manikhas, J. Cortés, -1

机译：编辑选择：非聚乙二醇脂质体阿霉素联合曲妥珠单抗和紫杉醇治疗HER2阳性转移性乳腺癌的III期试验
7. Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer [O] . J. Baselga, A. Manikhas, J. Cortés, 2014

机译：非缩缩脂质体DOXORUBICIN的期III试验与HER2阳性转移性乳腺癌中的曲妥珠单抗和紫杉醇组合

Results of a phase II study of liposomal doxorubicin (Myocet?) in combination with weekly paclitaxel and trastuzumab (Herceptin?) In patients with HER2-positive locally advanced or metastatic breast cancer (LA/MBC)

著录项

相似文献

相关主题

期刊订阅

Results of a phase II study of liposomal doxorubicin (Myocet^?) in combination with weekly paclitaxel and trastuzumab (Herceptin^?) In patients with HER2-positive locally advanced or metastatic breast cancer (LA/MBC)